Why It Matters

These approvals accelerate the shift toward minimally invasive, data‑driven procedures, reshaping hospital procurement and competitive dynamics in the med‑tech sector. The growing portfolio of robotic solutions promises improved outcomes and new revenue streams for manufacturers and providers alike.